Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2026 08:30 ET | Source: WallabyPhenox

WallabyPhenox Announces First U.S. Patient Treated with p48 & p64 MW HPC Flow Modulation Devices in PIANO IDE Trial

WallabyPhenox treats first U.S. patient in PIANO IDE trial using p48 & p64 MW HPC flow diverters for intracranial aneurysms.
March 18, 2026 08:30 ET | Source: WallabyPhenox

WallabyPhenox Restructures Debt and Accelerates Global Growth

WallabyPhenox completes financing to strengthen its balance sheet, support global expansion, and advance major neurovascular clinical programs.